New study aims to sharpen survival predictions for bone cancer patients
NCT ID NCT01470105
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involves 230 adults with cancer that has spread to their bones who need surgery. Researchers want to improve how doctors estimate survival by combining the patient's own health assessment with the doctor's evaluation. The goal is to create a more accurate prediction tool to help guide treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Preventive radiation may stop bone events before they start — a trial puts it to the test
- Can a new capsule ease bone metastasis pain without opioids?
- Hip muscle repair method may improve walking after bone cancer surgery
- New model aims to predict jaw bone disease before it strikes
- Could removing the primary tumor boost survival in stage IV breast cancer with Bone-Only spread?
- New 25-Minute bone scan could spot cancer faster with less radiation